We will lead our clients through difficult and demanding challenges.
We help pharmaceutical, biotech, and advanced-therapy teams define validation strategy, resolve evidence gaps, and plan responsible AI adoption.
Senior validation consultant and commissioning leader.
Move from promising pilots to clear intended uses, accountable decisions, and a proportionate evidence strategy. Our AI consulting connects the workflow to the quality system and the people responsible for it.
Prioritize uses, assess GxP impact and supplier evidence, and establish responsibilities before relying on AI outputs.
Prioritize uses, assess GxP impact and supplier evidence, and establish responsibilities before relying on AI outputs.
Use-case assessment · gap review · governance roadmap
Define requirements, evaluation tasks, acceptance criteria, and evidence needs around the consequences of error.
Define requirements, evaluation tasks, acceptance criteria, and evidence needs around the consequences of error.
Assurance planning · evaluation design · independent review
Keep sources, records, reviews, and meaningful model or workflow changes traceable through ongoing use.
Keep sources, records, reviews, and meaningful model or workflow changes traceable through ongoing use.
Control requirements · monitoring · change assessment
Engagements are scoped to the intended use and available evidence. Client Quality retains approval and release authority.
We partner with Quality, Engineering, Manufacturing, IT, and Operations to define validation strategy, prioritize risk, strengthen technical decisions, and guide execution across the system lifecycle.
Risk-based qualification for facilities, utilities, equipment, and manufacturing systems.
We lead risk-based C&Q strategy for facilities, utilities, cleanrooms, equipment, and manufacturing systems, aligning IQ, OQ, PQ, turnover, and startup activities to critical risks and intended use.
Explore commissioning and qualificationValidation strategy and lifecycle governance for regulated computerized systems.
We guide CSV strategy for laboratory, manufacturing, quality, and infrastructure systems, including intended-use definition, risk assessment, protocol strategy, evidence review, and lifecycle governance.
Explore CSV and data integrityConnect process knowledge, qualification strategy, and continued verification.
We advise on process-validation strategy, protocol and sampling rationale, evidence review, and continued process verification, with scope tied to the product, process, and lifecycle stage.
Explore process validationDefine cleaning strategy, study rationale, and evidence needs.
We help teams structure cleaning-validation strategy, review study rationale and existing evidence, and prioritize gaps in procedures, sampling, and lifecycle controls.
Explore cleaning validationAssess gaps, prioritize risks, and plan sustainable data controls.
We assess data-integrity and legacy-system risks, define remediation priorities, and guide Part 11 and quality-system corrective actions toward defensible, sustainable controls.
Qualification and lifecycle strategy for GMP and clean utilities.
We advise on qualification and lifecycle strategy for GMP and clean utilities, aligning system criticality, acceptance criteria, verification, and continued-state controls.
Storage qualification, temperature mapping, monitoring, and excursion controls.
We guide qualification strategy for controlled temperature units (CTUs), warehouses, and storage areas, including temperature mapping, monitoring, excursion controls, and lifecycle decisions.
Steam autoclaves, VHP cycles, and depyrogenation ovens and tunnels.
We guide cycle-validation and load-qualification strategy for steam autoclaves, bio-decontamination cycle development and qualification for vaporized hydrogen peroxide (VHP), and equipment qualification and process validation for depyrogenation ovens and tunnels.
Govern system changes, quality processes, and regulated documentation.
We advise clients on BMS, CMMS, quality systems, change control, procedural governance, and regulated documentation so system changes remain risk-based, traceable, and inspection-ready.
Validation strategy for advanced-therapy manufacturing systems.
We lead validation strategy for advanced-therapy operations, including cleanrooms, equipment, computerized systems, cold-chain controls, and evidence packages supporting cell and gene therapy manufacturing.
Plan startup, scale-up, transfer, remediation, and inspection readiness.
We partner with biologics and advanced-therapy teams preparing for scale-up, technology transfer, inspection readiness, remediation, or GMP manufacturing startup.
Keep patient-specific materials, systems, and records traceable.
We advise on validation and data controls where chain of identity, patient-specific materials, batch records, laboratory systems, CTUs, and electronic records must remain traceable and governed.
Agree a focused scope around the project stage, available evidence, and the people who need to act on the findings.
For a new project, startup, or a change in direction.
Starting inputs: Project objectives, system boundaries, current plans, and known constraints.
Reviewable outcome: A scoped assessment, priority risks, and a proposed validation roadmap.
Discuss this engagementFor a defined system, study, or package that needs a fresh technical review.
Starting inputs: Requirements, protocols, reports, supplier evidence, and open deviations.
Reviewable outcome: Findings linked to the evidence reviewed, remaining gaps, and recommendations for the next decision.
Discuss this engagementFor legacy gaps, incomplete closeout, or readiness concerns.
Starting inputs: Known findings, available records, current controls, and operational priorities.
Reviewable outcome: A staged action plan with priorities, dependencies, and proposed decision points.
Discuss this engagementScope, deliverables, timing, and specialist participation are agreed for each engagement. Proposed strategies and findings support client decisions; protocol authorization, Quality approval, and release remain with the client.
For gene therapy, viral-vector, CAR-T, cell-therapy, and biologics operations, we help teams coordinate validation decisions across startup, scale-up, technology transfer, and remediation.
John-Patrick Coane is a senior validation consultant and commissioning leader with 28 years of experience in pharmaceutical, biotechnology, and medical-device manufacturing environments. He advises clients on commissioning, qualification, process and cleaning validation, computer system validation, technical investigations, SOP strategy, remediation, gap assessment, and lifecycle governance for laboratory, utility, facility, and manufacturing systems.
His experience spans aseptic processing, autoclaves, CIP and SIP systems, cleanrooms, analytical instrumentation, technology transfer, facility startup, and leadership across Quality, Manufacturing, Engineering, Operations, and client stakeholders. He holds Master of Science and Bachelor of Science degrees in Chemical Engineering from the University of South Florida.
We structure engagements to clarify risk, align stakeholders, define validation strategy, guide implementation, and leave client teams with defensible decisions and sustainable controls.
We evaluate current-state documentation, system boundaries, risk, timelines, stakeholder needs, and compliance drivers.
We define the validation strategy, decision framework, priorities, deliverables, and practical sequencing with client stakeholders.
We lead technical decisions, protocol strategy, evidence review, deviation resolution, and cross-functional execution with the client team.
We confirm rationale, close critical actions, strengthen turnover evidence, and position the client team to maintain the validated state.
Tell us the decision you need to make, the project stage, and where the uncertainty lies. We will help clarify the scope, priorities, and next steps.
Your organization retains responsibility for protocol authorization, quality approval, change control, and release decisions. Keep initial inquiries high level; confidential records can be discussed after suitable information-sharing arrangements are established.
Share the system, risk, timeline, and decision you need to make. We’ll reply directly to discuss scope, priorities, and the right consulting approach. This tool prepares an email for you to review and send; it does not submit a message through the website.
Using webmail? Copy the inquiry and send it to jpc@protocallvalidation.com from your preferred email service.
